Pharmacogenomics Testing in Phase I Oncology Clinical Trials: Constructive Criticism Is Warranted

SIMPLE SUMMARY: Phase I clinical trials are a cornerstone of pharmaceutical development in oncology. Many studies have now attempted to incorporate pharmacogenomics into phase I studies; however, many of these studies have fundamental flaws that that preclude interpretation and application of their...

Descripción completa

Detalles Bibliográficos
Autores principales: Sissung, Tristan M., Figg, William D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909728/
https://www.ncbi.nlm.nih.gov/pubmed/35267440
http://dx.doi.org/10.3390/cancers14051131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909728/
https://www.ncbi.nlm.nih.gov/pubmed/35267440
http://dx.doi.org/10.3390/cancers14051131

Ejemplares similares